nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—chronic kidney failure—Calcium Acetate—osteoporosis	0.268	0.416	CpDpCtD
Cinacalcet—chronic kidney failure—Calcitriol—osteoporosis	0.203	0.315	CpDpCtD
Cinacalcet—chronic kidney failure—Cholecalciferol—osteoporosis	0.173	0.268	CpDpCtD
Cinacalcet—CYP1A2—Estropipate—osteoporosis	0.038	0.192	CbGbCtD
Cinacalcet—CASR—parathyroid gland—osteoporosis	0.0221	1	CbGeAlD
Cinacalcet—CYP3A4—Estropipate—osteoporosis	0.0199	0.101	CbGbCtD
Cinacalcet—CYP3A4—Calcitriol—osteoporosis	0.0199	0.101	CbGbCtD
Cinacalcet—CYP1A2—Conjugated Estrogens—osteoporosis	0.018	0.0909	CbGbCtD
Cinacalcet—CYP2D6—Cholecalciferol—osteoporosis	0.0161	0.0816	CbGbCtD
Cinacalcet—CYP3A4—Ergocalciferol—osteoporosis	0.0159	0.0805	CbGbCtD
Cinacalcet—CYP1A2—Estradiol—osteoporosis	0.0158	0.0798	CbGbCtD
Cinacalcet—CYP3A4—Raloxifene—osteoporosis	0.0133	0.0672	CbGbCtD
Cinacalcet—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0128	0.0649	CbGbCtD
Cinacalcet—CYP3A4—Cholecalciferol—osteoporosis	0.0102	0.0519	CbGbCtD
Cinacalcet—CYP3A4—Conjugated Estrogens—osteoporosis	0.0094	0.0476	CbGbCtD
Cinacalcet—CYP3A4—Estradiol—osteoporosis	0.00826	0.0418	CbGbCtD
Cinacalcet—CASR—G alpha (q) signalling events—MGLL—osteoporosis	0.000682	0.0535	CbGpPWpGaD
Cinacalcet—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000629	0.0493	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00061	0.0478	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PTH1R—osteoporosis	0.000433	0.0339	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CALCR—osteoporosis	0.000433	0.0339	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CNR2—osteoporosis	0.000366	0.0287	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CALCR—osteoporosis	0.000245	0.0192	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PTH1R—osteoporosis	0.000245	0.0192	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PTH—osteoporosis	0.000227	0.0178	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CALCR—osteoporosis	0.000222	0.0174	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PTH1R—osteoporosis	0.000222	0.0174	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CNR2—osteoporosis	0.000222	0.0174	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—WNT1—osteoporosis	0.000208	0.0163	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—ADCY5—osteoporosis	0.000195	0.0153	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—MGLL—osteoporosis	0.000194	0.0152	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—PTHLH—osteoporosis	0.000188	0.0148	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MGLL—osteoporosis	0.000177	0.0138	CbGpPWpGaD
Cinacalcet—Cough—Pamidronate—osteoporosis	0.000167	0.00135	CcSEcCtD
Cinacalcet—Constipation—Calcitriol—osteoporosis	0.000167	0.00135	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CALCA—osteoporosis	0.000166	0.013	CbGpPWpGaD
Cinacalcet—Convulsion—Pamidronate—osteoporosis	0.000166	0.00134	CcSEcCtD
Cinacalcet—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000165	0.00134	CcSEcCtD
Cinacalcet—Hypertension—Pamidronate—osteoporosis	0.000165	0.00134	CcSEcCtD
Cinacalcet—Urticaria—Estropipate—osteoporosis	0.000165	0.00134	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Raloxifene—osteoporosis	0.000165	0.00133	CcSEcCtD
Cinacalcet—Diarrhoea—Etidronic acid—osteoporosis	0.000164	0.00133	CcSEcCtD
Cinacalcet—Body temperature increased—Estropipate—osteoporosis	0.000164	0.00133	CcSEcCtD
Cinacalcet—Abdominal pain—Estropipate—osteoporosis	0.000164	0.00133	CcSEcCtD
Cinacalcet—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000164	0.00132	CcSEcCtD
Cinacalcet—Infection—Risedronate—osteoporosis	0.000163	0.00132	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Ibandronate—osteoporosis	0.000163	0.00132	CcSEcCtD
Cinacalcet—Arthralgia—Pamidronate—osteoporosis	0.000163	0.00132	CcSEcCtD
Cinacalcet—Myalgia—Pamidronate—osteoporosis	0.000163	0.00132	CcSEcCtD
Cinacalcet—Urticaria—Alendronate—osteoporosis	0.000163	0.00132	CcSEcCtD
Cinacalcet—Body temperature increased—Alendronate—osteoporosis	0.000162	0.00131	CcSEcCtD
Cinacalcet—Abdominal pain—Alendronate—osteoporosis	0.000162	0.00131	CcSEcCtD
Cinacalcet—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000162	0.00131	CcSEcCtD
Cinacalcet—Anaemia—Zoledronate—osteoporosis	0.000162	0.00131	CcSEcCtD
Cinacalcet—Nervous system disorder—Risedronate—osteoporosis	0.000161	0.0013	CcSEcCtD
Cinacalcet—Angioedema—Zoledronate—osteoporosis	0.00016	0.00129	CcSEcCtD
Cinacalcet—Skin disorder—Risedronate—osteoporosis	0.00016	0.00129	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Calcitriol—osteoporosis	0.00016	0.00129	CcSEcCtD
Cinacalcet—Body temperature increased—Raloxifene—osteoporosis	0.000159	0.00129	CcSEcCtD
Cinacalcet—Abdominal pain—Raloxifene—osteoporosis	0.000159	0.00129	CcSEcCtD
Cinacalcet—Urticaria—Ibandronate—osteoporosis	0.000158	0.00128	CcSEcCtD
Cinacalcet—Abdominal pain—Ibandronate—osteoporosis	0.000158	0.00127	CcSEcCtD
Cinacalcet—Body temperature increased—Ibandronate—osteoporosis	0.000158	0.00127	CcSEcCtD
Cinacalcet—Infection—Pamidronate—osteoporosis	0.000155	0.00125	CcSEcCtD
Cinacalcet—Urticaria—Calcitriol—osteoporosis	0.000155	0.00125	CcSEcCtD
Cinacalcet—Abdominal pain—Calcitriol—osteoporosis	0.000154	0.00125	CcSEcCtD
Cinacalcet—Body temperature increased—Calcitriol—osteoporosis	0.000154	0.00125	CcSEcCtD
Cinacalcet—Angioedema—Conjugated Estrogens—osteoporosis	0.000154	0.00124	CcSEcCtD
Cinacalcet—Hypersensitivity—Estropipate—osteoporosis	0.000153	0.00124	CcSEcCtD
Cinacalcet—Nervous system disorder—Pamidronate—osteoporosis	0.000153	0.00124	CcSEcCtD
Cinacalcet—Vomiting—Etidronic acid—osteoporosis	0.000153	0.00124	CcSEcCtD
Cinacalcet—Cough—Zoledronate—osteoporosis	0.000153	0.00123	CcSEcCtD
Cinacalcet—Oedema peripheral—Estradiol—osteoporosis	0.000152	0.00123	CcSEcCtD
Cinacalcet—Rash—Etidronic acid—osteoporosis	0.000152	0.00123	CcSEcCtD
Cinacalcet—Convulsion—Zoledronate—osteoporosis	0.000151	0.00122	CcSEcCtD
Cinacalcet—Dermatitis—Etidronic acid—osteoporosis	0.000151	0.00122	CcSEcCtD
Cinacalcet—Hypertension—Zoledronate—osteoporosis	0.000151	0.00122	CcSEcCtD
Cinacalcet—Hypersensitivity—Alendronate—osteoporosis	0.000151	0.00122	CcSEcCtD
Cinacalcet—Headache—Etidronic acid—osteoporosis	0.000151	0.00122	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00015	0.0118	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00015	0.00121	CcSEcCtD
Cinacalcet—Asthenia—Estropipate—osteoporosis	0.000149	0.00121	CcSEcCtD
Cinacalcet—Anorexia—Pamidronate—osteoporosis	0.000149	0.0012	CcSEcCtD
Cinacalcet—Myalgia—Zoledronate—osteoporosis	0.000149	0.0012	CcSEcCtD
Cinacalcet—Arthralgia—Zoledronate—osteoporosis	0.000149	0.0012	CcSEcCtD
Cinacalcet—Chest pain—Zoledronate—osteoporosis	0.000149	0.0012	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000148	0.0012	CcSEcCtD
Cinacalcet—Paraesthesia—Risedronate—osteoporosis	0.000148	0.00119	CcSEcCtD
Cinacalcet—Pruritus—Estropipate—osteoporosis	0.000147	0.00119	CcSEcCtD
Cinacalcet—Asthenia—Alendronate—osteoporosis	0.000147	0.00119	CcSEcCtD
Cinacalcet—Hypersensitivity—Ibandronate—osteoporosis	0.000147	0.00119	CcSEcCtD
Cinacalcet—Cough—Conjugated Estrogens—osteoporosis	0.000147	0.00119	CcSEcCtD
Cinacalcet—Dyspnoea—Risedronate—osteoporosis	0.000146	0.00118	CcSEcCtD
Cinacalcet—Hypotension—Pamidronate—osteoporosis	0.000146	0.00118	CcSEcCtD
Cinacalcet—Convulsion—Conjugated Estrogens—osteoporosis	0.000146	0.00118	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000145	0.00118	CcSEcCtD
Cinacalcet—Fatigue—Ethinyl Estradiol—osteoporosis	0.000145	0.00117	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SOST—osteoporosis	0.000145	0.0114	CbGpPWpGaD
Cinacalcet—Pruritus—Alendronate—osteoporosis	0.000145	0.00117	CcSEcCtD
Cinacalcet—Dyspepsia—Risedronate—osteoporosis	0.000145	0.00117	CcSEcCtD
Cinacalcet—Constipation—Ethinyl Estradiol—osteoporosis	0.000144	0.00117	CcSEcCtD
Cinacalcet—Hypersensitivity—Calcitriol—osteoporosis	0.000144	0.00116	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—POMC—osteoporosis	0.000143	0.0112	CbGpPWpGaD
Cinacalcet—Myalgia—Conjugated Estrogens—osteoporosis	0.000143	0.00116	CcSEcCtD
Cinacalcet—Chest pain—Conjugated Estrogens—osteoporosis	0.000143	0.00116	CcSEcCtD
Cinacalcet—Arthralgia—Conjugated Estrogens—osteoporosis	0.000143	0.00116	CcSEcCtD
Cinacalcet—Asthenia—Ibandronate—osteoporosis	0.000143	0.00116	CcSEcCtD
Cinacalcet—Nausea—Etidronic acid—osteoporosis	0.000143	0.00115	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000142	0.00115	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000142	0.00115	CcSEcCtD
Cinacalcet—Diarrhoea—Estropipate—osteoporosis	0.000142	0.00115	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Risedronate—osteoporosis	0.000142	0.00115	CcSEcCtD
Cinacalcet—Infection—Zoledronate—osteoporosis	0.000142	0.00115	CcSEcCtD
Cinacalcet—Fatigue—Risedronate—osteoporosis	0.000142	0.00115	CcSEcCtD
Cinacalcet—Pruritus—Ibandronate—osteoporosis	0.000141	0.00114	CcSEcCtD
Cinacalcet—Constipation—Risedronate—osteoporosis	0.000141	0.00114	CcSEcCtD
Cinacalcet—Paraesthesia—Pamidronate—osteoporosis	0.00014	0.00113	CcSEcCtD
Cinacalcet—Diarrhoea—Alendronate—osteoporosis	0.00014	0.00113	CcSEcCtD
Cinacalcet—Asthenia—Calcitriol—osteoporosis	0.00014	0.00113	CcSEcCtD
Cinacalcet—Nervous system disorder—Zoledronate—osteoporosis	0.00014	0.00113	CcSEcCtD
Cinacalcet—Immune system disorder—Estradiol—osteoporosis	0.00014	0.00113	CcSEcCtD
Cinacalcet—Dyspnoea—Pamidronate—osteoporosis	0.000139	0.00113	CcSEcCtD
Cinacalcet—Skin disorder—Zoledronate—osteoporosis	0.000139	0.00112	CcSEcCtD
Cinacalcet—Pruritus—Calcitriol—osteoporosis	0.000138	0.00112	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000138	0.00111	CcSEcCtD
Cinacalcet—Diarrhoea—Raloxifene—osteoporosis	0.000138	0.00111	CcSEcCtD
Cinacalcet—Dyspepsia—Pamidronate—osteoporosis	0.000137	0.00111	CcSEcCtD
Cinacalcet—Dizziness—Estropipate—osteoporosis	0.000137	0.00111	CcSEcCtD
Cinacalcet—Infection—Conjugated Estrogens—osteoporosis	0.000136	0.0011	CcSEcCtD
Cinacalcet—Diarrhoea—Ibandronate—osteoporosis	0.000136	0.0011	CcSEcCtD
Cinacalcet—Anorexia—Zoledronate—osteoporosis	0.000136	0.0011	CcSEcCtD
Cinacalcet—Decreased appetite—Pamidronate—osteoporosis	0.000136	0.0011	CcSEcCtD
Cinacalcet—Dizziness—Alendronate—osteoporosis	0.000135	0.0011	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000135	0.00109	CcSEcCtD
Cinacalcet—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000135	0.00109	CcSEcCtD
Cinacalcet—Malnutrition—Estradiol—osteoporosis	0.000135	0.00109	CcSEcCtD
Cinacalcet—Fatigue—Pamidronate—osteoporosis	0.000135	0.00109	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Risedronate—osteoporosis	0.000134	0.00109	CcSEcCtD
Cinacalcet—Urticaria—Ethinyl Estradiol—osteoporosis	0.000134	0.00108	CcSEcCtD
Cinacalcet—Constipation—Pamidronate—osteoporosis	0.000134	0.00108	CcSEcCtD
Cinacalcet—Diarrhoea—Calcitriol—osteoporosis	0.000134	0.00108	CcSEcCtD
Cinacalcet—Skin disorder—Conjugated Estrogens—osteoporosis	0.000133	0.00108	CcSEcCtD
Cinacalcet—Hypotension—Zoledronate—osteoporosis	0.000133	0.00108	CcSEcCtD
Cinacalcet—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000133	0.00108	CcSEcCtD
Cinacalcet—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000133	0.00108	CcSEcCtD
Cinacalcet—Dizziness—Raloxifene—osteoporosis	0.000133	0.00108	CcSEcCtD
Cinacalcet—Vomiting—Estropipate—osteoporosis	0.000132	0.00107	CcSEcCtD
Cinacalcet—Dizziness—Ibandronate—osteoporosis	0.000132	0.00107	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CALCR—osteoporosis	0.000131	0.0103	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTH1R—osteoporosis	0.000131	0.0103	CbGpPWpGaD
Cinacalcet—Rash—Estropipate—osteoporosis	0.000131	0.00106	CcSEcCtD
Cinacalcet—Dermatitis—Estropipate—osteoporosis	0.000131	0.00106	CcSEcCtD
Cinacalcet—Anorexia—Conjugated Estrogens—osteoporosis	0.000131	0.00106	CcSEcCtD
Cinacalcet—Urticaria—Risedronate—osteoporosis	0.000131	0.00106	CcSEcCtD
Cinacalcet—Headache—Estropipate—osteoporosis	0.00013	0.00105	CcSEcCtD
Cinacalcet—Vomiting—Alendronate—osteoporosis	0.00013	0.00105	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00013	0.00105	CcSEcCtD
Cinacalcet—Abdominal pain—Risedronate—osteoporosis	0.00013	0.00105	CcSEcCtD
Cinacalcet—Body temperature increased—Risedronate—osteoporosis	0.00013	0.00105	CcSEcCtD
Cinacalcet—Muscle spasms—Estradiol—osteoporosis	0.00013	0.00105	CcSEcCtD
Cinacalcet—Rash—Alendronate—osteoporosis	0.000129	0.00104	CcSEcCtD
Cinacalcet—Dermatitis—Alendronate—osteoporosis	0.000129	0.00104	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PTH—osteoporosis	0.000129	0.0101	CbGpPWpGaD
Cinacalcet—Hypotension—Conjugated Estrogens—osteoporosis	0.000128	0.00104	CcSEcCtD
Cinacalcet—Headache—Alendronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Cinacalcet—Paraesthesia—Zoledronate—osteoporosis	0.000128	0.00104	CcSEcCtD
Cinacalcet—Vomiting—Raloxifene—osteoporosis	0.000128	0.00104	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Pamidronate—osteoporosis	0.000128	0.00103	CcSEcCtD
Cinacalcet—Dyspnoea—Zoledronate—osteoporosis	0.000127	0.00103	CcSEcCtD
Cinacalcet—Rash—Raloxifene—osteoporosis	0.000127	0.00103	CcSEcCtD
Cinacalcet—Dermatitis—Raloxifene—osteoporosis	0.000127	0.00103	CcSEcCtD
Cinacalcet—Vomiting—Ibandronate—osteoporosis	0.000127	0.00103	CcSEcCtD
Cinacalcet—Headache—Raloxifene—osteoporosis	0.000126	0.00102	CcSEcCtD
Cinacalcet—Rash—Ibandronate—osteoporosis	0.000126	0.00102	CcSEcCtD
Cinacalcet—Dermatitis—Ibandronate—osteoporosis	0.000126	0.00102	CcSEcCtD
Cinacalcet—Dyspepsia—Zoledronate—osteoporosis	0.000126	0.00102	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CNR2—osteoporosis	0.000125	0.00982	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000125	0.00101	CcSEcCtD
Cinacalcet—Headache—Ibandronate—osteoporosis	0.000125	0.00101	CcSEcCtD
Cinacalcet—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000124	0.001	CcSEcCtD
Cinacalcet—Vomiting—Calcitriol—osteoporosis	0.000124	0.001	CcSEcCtD
Cinacalcet—Decreased appetite—Zoledronate—osteoporosis	0.000124	0.001	CcSEcCtD
Cinacalcet—Nausea—Estropipate—osteoporosis	0.000123	0.000999	CcSEcCtD
Cinacalcet—Abdominal pain—Pamidronate—osteoporosis	0.000123	0.000999	CcSEcCtD
Cinacalcet—Body temperature increased—Pamidronate—osteoporosis	0.000123	0.000999	CcSEcCtD
Cinacalcet—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000123	0.000998	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000123	0.00966	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000123	0.000996	CcSEcCtD
Cinacalcet—Angioedema—Estradiol—osteoporosis	0.000123	0.000995	CcSEcCtD
Cinacalcet—Rash—Calcitriol—osteoporosis	0.000123	0.000995	CcSEcCtD
Cinacalcet—Fatigue—Zoledronate—osteoporosis	0.000123	0.000995	CcSEcCtD
Cinacalcet—Dermatitis—Calcitriol—osteoporosis	0.000123	0.000994	CcSEcCtD
Cinacalcet—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000122	0.00099	CcSEcCtD
Cinacalcet—Headache—Calcitriol—osteoporosis	0.000122	0.000989	CcSEcCtD
Cinacalcet—Constipation—Zoledronate—osteoporosis	0.000122	0.000987	CcSEcCtD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000122	0.00956	CbGpPWpGaD
Cinacalcet—Nausea—Alendronate—osteoporosis	0.000122	0.000984	CcSEcCtD
Cinacalcet—Hypersensitivity—Risedronate—osteoporosis	0.000121	0.000979	CcSEcCtD
Cinacalcet—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000121	0.000978	CcSEcCtD
Cinacalcet—Asthenia—Ethinyl Estradiol—osteoporosis	0.000121	0.000978	CcSEcCtD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00012	0.00944	CbGpPWpGaD
Cinacalcet—Nausea—Raloxifene—osteoporosis	0.00012	0.000967	CcSEcCtD
Cinacalcet—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000119	0.000966	CcSEcCtD
Cinacalcet—Pruritus—Ethinyl Estradiol—osteoporosis	0.000119	0.000964	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000119	0.000959	CcSEcCtD
Cinacalcet—Fatigue—Conjugated Estrogens—osteoporosis	0.000118	0.000958	CcSEcCtD
Cinacalcet—Nausea—Ibandronate—osteoporosis	0.000118	0.000958	CcSEcCtD
Cinacalcet—Asthenia—Risedronate—osteoporosis	0.000118	0.000953	CcSEcCtD
Cinacalcet—Cough—Estradiol—osteoporosis	0.000118	0.000951	CcSEcCtD
Cinacalcet—Constipation—Conjugated Estrogens—osteoporosis	0.000117	0.00095	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PTH—osteoporosis	0.000117	0.00915	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Zoledronate—osteoporosis	0.000117	0.000943	CcSEcCtD
Cinacalcet—Hypertension—Estradiol—osteoporosis	0.000116	0.000941	CcSEcCtD
Cinacalcet—Pruritus—Risedronate—osteoporosis	0.000116	0.00094	CcSEcCtD
Cinacalcet—Nausea—Calcitriol—osteoporosis	0.000116	0.000938	CcSEcCtD
Cinacalcet—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000115	0.000932	CcSEcCtD
Cinacalcet—Hypersensitivity—Pamidronate—osteoporosis	0.000115	0.000931	CcSEcCtD
Cinacalcet—Myalgia—Estradiol—osteoporosis	0.000115	0.000928	CcSEcCtD
Cinacalcet—Arthralgia—Estradiol—osteoporosis	0.000115	0.000928	CcSEcCtD
Cinacalcet—Chest pain—Estradiol—osteoporosis	0.000115	0.000928	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000114	0.000921	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CNR2—osteoporosis	0.000114	0.00892	CbGpPWpGaD
Cinacalcet—Urticaria—Zoledronate—osteoporosis	0.000113	0.000917	CcSEcCtD
Cinacalcet—Body temperature increased—Zoledronate—osteoporosis	0.000113	0.000912	CcSEcCtD
Cinacalcet—Abdominal pain—Zoledronate—osteoporosis	0.000113	0.000912	CcSEcCtD
Cinacalcet—Diarrhoea—Risedronate—osteoporosis	0.000112	0.000909	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000112	0.000908	CcSEcCtD
Cinacalcet—Asthenia—Pamidronate—osteoporosis	0.000112	0.000906	CcSEcCtD
Cinacalcet—Dizziness—Ethinyl Estradiol—osteoporosis	0.000111	0.000901	CcSEcCtD
Cinacalcet—Pruritus—Pamidronate—osteoporosis	0.000111	0.000894	CcSEcCtD
Cinacalcet—Infection—Estradiol—osteoporosis	0.000109	0.000883	CcSEcCtD
Cinacalcet—Urticaria—Conjugated Estrogens—osteoporosis	0.000109	0.000883	CcSEcCtD
Cinacalcet—Dizziness—Risedronate—osteoporosis	0.000109	0.000879	CcSEcCtD
Cinacalcet—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000109	0.000878	CcSEcCtD
Cinacalcet—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000109	0.000878	CcSEcCtD
Cinacalcet—Nervous system disorder—Estradiol—osteoporosis	0.000108	0.000872	CcSEcCtD
Cinacalcet—Vomiting—Ethinyl Estradiol—osteoporosis	0.000107	0.000867	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—WNT1—osteoporosis	0.000107	0.00838	CbGpPWpGaD
Cinacalcet—Diarrhoea—Pamidronate—osteoporosis	0.000107	0.000864	CcSEcCtD
Cinacalcet—Skin disorder—Estradiol—osteoporosis	0.000107	0.000864	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PTHLH—osteoporosis	0.000107	0.00835	CbGpPWpGaD
Cinacalcet—Rash—Ethinyl Estradiol—osteoporosis	0.000106	0.000859	CcSEcCtD
Cinacalcet—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000106	0.000859	CcSEcCtD
Cinacalcet—Headache—Ethinyl Estradiol—osteoporosis	0.000106	0.000854	CcSEcCtD
Cinacalcet—Hypersensitivity—Zoledronate—osteoporosis	0.000105	0.00085	CcSEcCtD
Cinacalcet—Vomiting—Risedronate—osteoporosis	0.000104	0.000845	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—MGLL—osteoporosis	0.000104	0.00818	CbGpPWpGaD
Cinacalcet—Rash—Risedronate—osteoporosis	0.000104	0.000838	CcSEcCtD
Cinacalcet—Dermatitis—Risedronate—osteoporosis	0.000104	0.000837	CcSEcCtD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000103	0.0081	CbGpPWpGaD
Cinacalcet—Dizziness—Pamidronate—osteoporosis	0.000103	0.000835	CcSEcCtD
Cinacalcet—Headache—Risedronate—osteoporosis	0.000103	0.000832	CcSEcCtD
Cinacalcet—Asthenia—Zoledronate—osteoporosis	0.000102	0.000828	CcSEcCtD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000102	0.008	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LRP5—osteoporosis	0.000102	0.00798	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000101	0.000819	CcSEcCtD
Cinacalcet—Pruritus—Zoledronate—osteoporosis	0.000101	0.000816	CcSEcCtD
Cinacalcet—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.0001	0.00788	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Estradiol—osteoporosis	0.0001	0.00081	CcSEcCtD
Cinacalcet—Nausea—Ethinyl Estradiol—osteoporosis	0.0001	0.00081	CcSEcCtD
Cinacalcet—Vomiting—Pamidronate—osteoporosis	9.93e-05	0.000803	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.89e-05	0.00775	CbGpPWpGaD
Cinacalcet—Paraesthesia—Estradiol—osteoporosis	9.87e-05	0.000798	CcSEcCtD
Cinacalcet—Asthenia—Conjugated Estrogens—osteoporosis	9.86e-05	0.000797	CcSEcCtD
Cinacalcet—Rash—Pamidronate—osteoporosis	9.85e-05	0.000796	CcSEcCtD
Cinacalcet—Dermatitis—Pamidronate—osteoporosis	9.84e-05	0.000796	CcSEcCtD
Cinacalcet—Dyspnoea—Estradiol—osteoporosis	9.8e-05	0.000793	CcSEcCtD
Cinacalcet—Headache—Pamidronate—osteoporosis	9.79e-05	0.000791	CcSEcCtD
Cinacalcet—Diarrhoea—Zoledronate—osteoporosis	9.76e-05	0.000789	CcSEcCtD
Cinacalcet—Nausea—Risedronate—osteoporosis	9.76e-05	0.000789	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—LRP6—osteoporosis	9.73e-05	0.00763	CbGpPWpGaD
Cinacalcet—Pruritus—Conjugated Estrogens—osteoporosis	9.72e-05	0.000786	CcSEcCtD
Cinacalcet—Dyspepsia—Estradiol—osteoporosis	9.68e-05	0.000783	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PTHLH—osteoporosis	9.67e-05	0.00758	CbGpPWpGaD
Cinacalcet—Decreased appetite—Estradiol—osteoporosis	9.56e-05	0.000773	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Estradiol—osteoporosis	9.49e-05	0.000768	CcSEcCtD
Cinacalcet—Fatigue—Estradiol—osteoporosis	9.48e-05	0.000767	CcSEcCtD
Cinacalcet—Dizziness—Zoledronate—osteoporosis	9.43e-05	0.000763	CcSEcCtD
Cinacalcet—Constipation—Estradiol—osteoporosis	9.4e-05	0.00076	CcSEcCtD
Cinacalcet—Diarrhoea—Conjugated Estrogens—osteoporosis	9.4e-05	0.00076	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CALCA—osteoporosis	9.38e-05	0.00735	CbGpPWpGaD
Cinacalcet—Nausea—Pamidronate—osteoporosis	9.28e-05	0.00075	CcSEcCtD
Cinacalcet—Dizziness—Conjugated Estrogens—osteoporosis	9.08e-05	0.000735	CcSEcCtD
Cinacalcet—Vomiting—Zoledronate—osteoporosis	9.07e-05	0.000734	CcSEcCtD
Cinacalcet—Rash—Zoledronate—osteoporosis	9e-05	0.000727	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Estradiol—osteoporosis	8.99e-05	0.000727	CcSEcCtD
Cinacalcet—Dermatitis—Zoledronate—osteoporosis	8.99e-05	0.000727	CcSEcCtD
Cinacalcet—Headache—Zoledronate—osteoporosis	8.94e-05	0.000723	CcSEcCtD
Cinacalcet—Vomiting—Conjugated Estrogens—osteoporosis	8.73e-05	0.000706	CcSEcCtD
Cinacalcet—Urticaria—Estradiol—osteoporosis	8.73e-05	0.000706	CcSEcCtD
Cinacalcet—Abdominal pain—Estradiol—osteoporosis	8.69e-05	0.000703	CcSEcCtD
Cinacalcet—Body temperature increased—Estradiol—osteoporosis	8.69e-05	0.000703	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—POMC—osteoporosis	8.68e-05	0.00681	CbGpPWpGaD
Cinacalcet—Rash—Conjugated Estrogens—osteoporosis	8.66e-05	0.0007	CcSEcCtD
Cinacalcet—Dermatitis—Conjugated Estrogens—osteoporosis	8.65e-05	0.0007	CcSEcCtD
Cinacalcet—Headache—Conjugated Estrogens—osteoporosis	8.61e-05	0.000696	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CALCA—osteoporosis	8.51e-05	0.00668	CbGpPWpGaD
Cinacalcet—Nausea—Zoledronate—osteoporosis	8.47e-05	0.000685	CcSEcCtD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.38e-05	0.00657	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TLN1—osteoporosis	8.22e-05	0.00644	CbGpPWpGaD
Cinacalcet—Nausea—Conjugated Estrogens—osteoporosis	8.16e-05	0.00066	CcSEcCtD
Cinacalcet—Hypersensitivity—Estradiol—osteoporosis	8.1e-05	0.000655	CcSEcCtD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	7.98e-05	0.00625	CbGpPWpGaD
Cinacalcet—Asthenia—Estradiol—osteoporosis	7.89e-05	0.000638	CcSEcCtD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	7.87e-05	0.00617	CbGpPWpGaD
Cinacalcet—Pruritus—Estradiol—osteoporosis	7.78e-05	0.000629	CcSEcCtD
Cinacalcet—Diarrhoea—Estradiol—osteoporosis	7.52e-05	0.000608	CcSEcCtD
Cinacalcet—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	7.52e-05	0.00589	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.47e-05	0.00586	CbGpPWpGaD
Cinacalcet—Dizziness—Estradiol—osteoporosis	7.27e-05	0.000588	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—P4HB—osteoporosis	7.09e-05	0.00556	CbGpPWpGaD
Cinacalcet—Vomiting—Estradiol—osteoporosis	6.99e-05	0.000565	CcSEcCtD
Cinacalcet—Rash—Estradiol—osteoporosis	6.93e-05	0.000561	CcSEcCtD
Cinacalcet—Dermatitis—Estradiol—osteoporosis	6.93e-05	0.00056	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PTH—osteoporosis	6.9e-05	0.00541	CbGpPWpGaD
Cinacalcet—Headache—Estradiol—osteoporosis	6.89e-05	0.000557	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—RAP1A—osteoporosis	6.78e-05	0.00531	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CNR2—osteoporosis	6.72e-05	0.00527	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	6.71e-05	0.00526	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.69e-05	0.00525	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—ADCY5—osteoporosis	6.67e-05	0.00523	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFATC1—osteoporosis	6.61e-05	0.00518	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—DKK1—osteoporosis	6.56e-05	0.00514	CbGpPWpGaD
Cinacalcet—Nausea—Estradiol—osteoporosis	6.53e-05	0.000528	CcSEcCtD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	6.47e-05	0.00507	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	6.41e-05	0.00502	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	6.32e-05	0.00496	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—WNT1—osteoporosis	6.32e-05	0.00495	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGA—osteoporosis	6.15e-05	0.00482	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—ADCY5—osteoporosis	6.06e-05	0.00475	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	5.77e-05	0.00452	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTHLH—osteoporosis	5.71e-05	0.00448	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BMP2—osteoporosis	5.71e-05	0.00448	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGB—osteoporosis	5.59e-05	0.00438	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.43e-05	0.00426	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PSMA5—osteoporosis	5.4e-05	0.00423	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PSMA2—osteoporosis	5.4e-05	0.00423	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.36e-05	0.0042	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	5.25e-05	0.00412	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.2e-05	0.00407	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	5.18e-05	0.00406	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	5.18e-05	0.00406	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	5.11e-05	0.00401	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CALCA—osteoporosis	5.03e-05	0.00394	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—POMC—osteoporosis	4.91e-05	0.00385	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KL—osteoporosis	4.57e-05	0.00358	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	4.48e-05	0.00352	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—POMC—osteoporosis	4.46e-05	0.00349	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	4.45e-05	0.00349	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.4e-05	0.00345	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	4.39e-05	0.00344	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6R—osteoporosis	4.35e-05	0.00341	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.19e-05	0.00329	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.13e-05	0.00324	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.85e-05	0.00302	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ADCY5—osteoporosis	3.58e-05	0.00281	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SPP1—osteoporosis	3.46e-05	0.00271	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.43e-05	0.00269	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.4e-05	0.00266	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.39e-05	0.00266	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.26e-05	0.00256	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IRS2—osteoporosis	3.13e-05	0.00245	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.12e-05	0.00245	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LEP—osteoporosis	3.06e-05	0.0024	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	2.99e-05	0.00235	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.98e-05	0.00233	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ESR1—osteoporosis	2.92e-05	0.00229	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.82e-05	0.00221	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	2.76e-05	0.00216	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IRS1—osteoporosis	2.73e-05	0.00214	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.72e-05	0.00213	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.64e-05	0.00207	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—POMC—osteoporosis	2.63e-05	0.00206	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6R—osteoporosis	2.57e-05	0.00201	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IGF1—osteoporosis	2.53e-05	0.00198	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.52e-05	0.00197	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.34e-05	0.00183	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.33e-05	0.00183	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.33e-05	0.00182	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	2.31e-05	0.00181	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.19e-05	0.00172	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.17e-05	0.0017	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.17e-05	0.0017	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.14e-05	0.00168	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.04e-05	0.0016	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—osteoporosis	1.94e-05	0.00152	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.8e-05	0.00141	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.78e-05	0.0014	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.71e-05	0.00134	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—POMC—osteoporosis	1.66e-05	0.0013	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PKM—osteoporosis	1.56e-05	0.00123	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—FDPS—osteoporosis	1.56e-05	0.00123	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—osteoporosis	1.52e-05	0.00119	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—osteoporosis	1.52e-05	0.00119	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PGLS—osteoporosis	1.48e-05	0.00116	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GPD2—osteoporosis	1.48e-05	0.00116	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.45e-05	0.00114	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—POMC—osteoporosis	1.41e-05	0.0011	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PNP—osteoporosis	1.36e-05	0.00106	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ATIC—osteoporosis	1.36e-05	0.00106	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PKM—osteoporosis	1.33e-05	0.00104	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—FDPS—osteoporosis	1.33e-05	0.00104	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GPD2—osteoporosis	1.26e-05	0.000985	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PGLS—osteoporosis	1.26e-05	0.000985	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—OXCT1—osteoporosis	1.15e-05	0.000904	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA2—osteoporosis	1.15e-05	0.000904	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PNP—osteoporosis	1.15e-05	0.000901	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ATIC—osteoporosis	1.15e-05	0.000901	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—osteoporosis	1.14e-05	0.000897	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MGLL—osteoporosis	1.12e-05	0.000881	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—POMC—osteoporosis	1.08e-05	0.00085	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PKM—osteoporosis	1.02e-05	0.000802	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—FDPS—osteoporosis	1.02e-05	0.000802	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—OXCT1—osteoporosis	9.77e-06	0.000766	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA2—osteoporosis	9.77e-06	0.000766	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GPD2—osteoporosis	9.69e-06	0.00076	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PGLS—osteoporosis	9.69e-06	0.00076	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—IDH2—osteoporosis	9.56e-06	0.000749	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MGLL—osteoporosis	9.52e-06	0.000746	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP27A1—osteoporosis	8.98e-06	0.000704	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.98e-06	0.000704	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PNP—osteoporosis	8.87e-06	0.000695	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ATIC—osteoporosis	8.87e-06	0.000695	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACP5—osteoporosis	8.74e-06	0.000685	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TPI1—osteoporosis	8.12e-06	0.000637	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—IDH2—osteoporosis	8.09e-06	0.000635	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—P4HB—osteoporosis	7.64e-06	0.000599	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP27A1—osteoporosis	7.61e-06	0.000597	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA2—osteoporosis	7.54e-06	0.000591	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—OXCT1—osteoporosis	7.54e-06	0.000591	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GAPDH—osteoporosis	7.5e-06	0.000588	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACP5—osteoporosis	7.4e-06	0.00058	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MGLL—osteoporosis	7.35e-06	0.000576	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.31e-06	0.000573	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—RAP1A—osteoporosis	7.3e-06	0.000573	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TPI1—osteoporosis	6.88e-06	0.00054	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—P4HB—osteoporosis	6.47e-06	0.000507	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GAPDH—osteoporosis	6.35e-06	0.000498	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—IDH2—osteoporosis	6.25e-06	0.00049	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—RAP1A—osteoporosis	6.19e-06	0.000485	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ENO1—osteoporosis	5.9e-06	0.000463	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.87e-06	0.000461	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PSMA2—osteoporosis	5.82e-06	0.000456	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PSMA5—osteoporosis	5.82e-06	0.000456	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACP5—osteoporosis	5.71e-06	0.000448	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.4e-06	0.000423	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TPI1—osteoporosis	5.31e-06	0.000416	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ENO1—osteoporosis	5e-06	0.000392	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—P4HB—osteoporosis	4.99e-06	0.000392	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PSMA2—osteoporosis	4.93e-06	0.000386	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PSMA5—osteoporosis	4.93e-06	0.000386	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GAPDH—osteoporosis	4.9e-06	0.000384	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—RAP1A—osteoporosis	4.77e-06	0.000374	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.72e-06	0.00037	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP19A1—osteoporosis	4e-06	0.000313	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ENO1—osteoporosis	3.86e-06	0.000303	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ADCY5—osteoporosis	3.86e-06	0.000302	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GPX1—osteoporosis	3.84e-06	0.000301	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PSMA2—osteoporosis	3.8e-06	0.000298	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PSMA5—osteoporosis	3.8e-06	0.000298	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—osteoporosis	3.55e-06	0.000278	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ADCY5—osteoporosis	3.27e-06	0.000256	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GPX1—osteoporosis	3.26e-06	0.000255	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.09e-06	0.000242	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—osteoporosis	3e-06	0.000236	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—POMC—osteoporosis	2.84e-06	0.000222	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ADCY5—osteoporosis	2.52e-06	0.000198	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GPX1—osteoporosis	2.51e-06	0.000197	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—POMC—osteoporosis	2.4e-06	0.000188	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—osteoporosis	2.32e-06	0.000182	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—POMC—osteoporosis	1.85e-06	0.000145	CbGpPWpGaD
